Te-Hui Chou

1.0k total citations
18 papers, 782 citations indexed

About

Te-Hui Chou is a scholar working on Virology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Te-Hui Chou has authored 18 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Virology, 9 papers in Molecular Biology and 7 papers in Infectious Diseases. Recurrent topics in Te-Hui Chou's work include HIV Research and Treatment (8 papers), vaccines and immunoinformatics approaches (5 papers) and Immunotherapy and Immune Responses (5 papers). Te-Hui Chou is often cited by papers focused on HIV Research and Treatment (8 papers), vaccines and immunoinformatics approaches (5 papers) and Immunotherapy and Immune Responses (5 papers). Te-Hui Chou collaborates with scholars based in United States, China and France. Te-Hui Chou's co-authors include Shan Lu, Shixia Wang, Pavlo Sakhatskyy, Siyuan Shen, Innocent Mboudjeka, Jean M. Lawrence, Feng He, Fangjun Liu, Swati Joshi and Gary J. Nabel and has published in prestigious journals such as Journal of Virology, Science Translational Medicine and Virology.

In The Last Decade

Te-Hui Chou

18 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Te-Hui Chou United States 15 331 311 310 244 221 18 782
Annalena La Porte United States 8 451 1.4× 553 1.8× 320 1.0× 242 1.0× 204 0.9× 11 864
Maureen F. Maughan United States 12 360 1.1× 226 0.7× 268 0.9× 253 1.0× 314 1.4× 17 840
D B Weiner United States 12 423 1.3× 340 1.1× 337 1.1× 207 0.8× 195 0.9× 19 817
Wolfgang Mundt Austria 17 217 0.7× 186 0.6× 281 0.9× 334 1.4× 346 1.6× 26 974
Nathaniel L. Simmons United States 12 559 1.7× 599 1.9× 381 1.2× 284 1.2× 253 1.1× 14 1.1k
Andreas Bråve Sweden 20 496 1.5× 348 1.1× 388 1.3× 261 1.1× 265 1.2× 56 1.1k
Nicole Chenciner France 16 257 0.8× 347 1.1× 222 0.7× 351 1.4× 266 1.2× 27 886
Minoru Kidokoro Japan 15 419 1.3× 175 0.6× 239 0.8× 273 1.1× 319 1.4× 33 966
Jens Wild Germany 16 404 1.2× 184 0.6× 297 1.0× 288 1.2× 99 0.4× 29 785
Zimra R. Israel United States 16 489 1.5× 539 1.7× 206 0.7× 304 1.2× 236 1.1× 21 888

Countries citing papers authored by Te-Hui Chou

Since Specialization
Citations

This map shows the geographic impact of Te-Hui Chou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Te-Hui Chou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Te-Hui Chou more than expected).

Fields of papers citing papers by Te-Hui Chou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Te-Hui Chou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Te-Hui Chou. The network helps show where Te-Hui Chou may publish in the future.

Co-authorship network of co-authors of Te-Hui Chou

This figure shows the co-authorship network connecting the top 25 collaborators of Te-Hui Chou. A scholar is included among the top collaborators of Te-Hui Chou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Te-Hui Chou. Te-Hui Chou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wei, Chih‐Jen, Wei Bu, Laura A. Nguyen, et al.. (2022). A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice. Science Translational Medicine. 14(643). eabf3685–eabf3685. 64 indexed citations
2.
Darricarrère, Nicole, Yu Qiu, Masaru Kanekiyo, et al.. (2021). Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates. Science Translational Medicine. 13(583). 46 indexed citations
3.
Darricarrère, Nicole, Xiaochu Duan, Rebecca S. Rudicell, et al.. (2018). Development of a Pan-H1 Influenza Vaccine. Journal of Virology. 92(22). 33 indexed citations
4.
Wang, Shixia, Te-Hui Chou, Yan Wang, et al.. (2017). Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines. Human Vaccines & Immunotherapeutics. 13(12). 2996–3009. 8 indexed citations
6.
Huang, Zuhu, Siyuan Shen, Innocent Mboudjeka, et al.. (2008). Levels of N-linked Glycosylation on the V1 Loop of HIV-1 Env Proteins and their Relationship to the Antigenicity of Env from Primary Viral Isolates. Current HIV Research. 6(4). 296–305. 5 indexed citations
7.
Sakhatskyy, Pavlo, Shixia Wang, Chuanyou Zhang, et al.. (2007). Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens. Virology. 371(1). 98–107. 32 indexed citations
9.
Sakhatskyy, Pavlo, Shixia Wang, Te-Hui Chou, & Shan Lu. (2006). Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen. Virology. 355(2). 164–174. 61 indexed citations
10.
Cristillo, Anthony D., Shixia Wang, Leilei He, et al.. (2005). Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine. Virology. 346(1). 151–168. 38 indexed citations
13.
Hurwitz, J, Karen S. Slobod, Timothy Lockey, et al.. (2005). Application of the Polyvalent Approach to HIV-1 Vaccine Development. PubMed. 5(2). 143–156. 30 indexed citations
14.
Wang, Shixia, Te-Hui Chou, Pavlo Sakhatskyy, et al.. (2005). Identification of Two Neutralizing Regions on the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Produced from the Mammalian Expression System. Journal of Virology. 79(3). 1906–1910. 66 indexed citations
15.
Wang, Shixia, James Arthos, Jean M. Lawrence, et al.. (2005). Enhanced Immunogenicity of gp120 Protein When Combined with Recombinant DNA Priming To Generate Antibodies That Neutralize the JR-FL Primary Isolate of Human Immunodeficiency Virus Type 1. Journal of Virology. 79(12). 7933–7937. 77 indexed citations
16.
Wang, Shixia, Destin W. Heilman, Fangjun Liu, et al.. (2004). A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague. Vaccine. 22(25-26). 3348–3357. 79 indexed citations
17.
Chou, Te-Hui, et al.. (2004). Gene Delivery Using Physical Methods: An Overview. Humana Press eBooks. 245. 147–166. 17 indexed citations
18.
Liu, Fangjun, Innocent Mboudjeka, Siyuan Shen, et al.. (2004). Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model. Vaccine. 22(13-14). 1764–1772. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026